-4.85%07-07“The echo of SK Hynix's IPO bell hadn't faded before one Korean research note yanked the whole memory complex back to earth — but a company that's pre-sold capacity through 2027 doesn't get sentenced on someone else's bad news; above $880 this is just the supercycle taking a deep breath”
Score8/10Day / week -4.3% / -7.0%RSI(14) 46.2WSB mentions 394 (nearly 2x in 24h, rank #1)SMA50 support $907Consensus target $1,579 (+68%)
Technicals — Pulled back to a step above the 50-day at $907 — the $920 add-watch zone flagged last issue has arrived. RSI at 46 is neutral and volume ran at just 0.7x, so the decline came without panic distribution. Overhead: the 20-day at $1,051 and the 52-week high at $1,255.
Fundamentals — Guidance was just raised on July 9 on surging memory pricing: cloud-memory revenue up 78% sequentially at an 83% gross margin, data-center revenue up 103%. HBM is sold out for 2026 and fully pre-sold through 2027. Nothing on this line changed today.
News — SK Hynix suffered its worst one-day drop on record (-15.4%) after Korean broker KIS cut its Q2 estimate 8% below consensus on slower HBM4 shipments, compounding post-Nasdaq-debut profit-taking; the KOSPI fell 9.95% and tripped a circuit breaker. US memory names sold off in sympathy — MU, SanDisk and WDC all took the hit.
Short-term · 1–3 weeks
LongBullish
Shrinking volume, 50-day support and zero fundamental change — all three marks of a pullback rather than a reversal. A break of $880 (half an ATR under the 50-day) would mean the market has started pricing a cycle top; execute the stop unconditionally there.
Entry Hold; $900–920 (the 50-day support band) is the add-watch zoneStop $880Target $1,150
Long-term · months+
Accumulate
Memory supercycle plus HBM pricing power; capacity pre-sold through 2027 gives rare revenue visibility, and the structural AI-memory shortage hasn't closed.
Signal BacktestCumulative -4.85%price itself -9.23%profitable since 07-10
07-07Long$984.75 → open → $937-4.85%
Community Voices
WSB · Mentions surged from 206 to 394 in 24h to take the #1 spot — bulls shouting 'gift dip' and bears shouting 'cycle top' in the same threadOriginal ↗
Institutional Views
华尔街共识 · 53 analysts average $1,579 — 68% above spot; 1.14 rating, near strong buy
TradingKey · The Anthropic deal plus a 22% pullback frame the buy-the-dip debateSource ↗
Motley Fool · The pricing cycle isn't done: prices still rising across the portfolio amid constrained supplySource ↗
0.00%07-02“The dip-buyers have queued for nine straight days, and every day someone thought they'd caught the knife — an RSI of 27 is a thermometer, not an entry signal; let it first prove it can print one decent doji before anyone talks about courage”
Technicals — Broke the $135 support and printed a fresh 52-week low at $131.35 intraday. All three moving averages cap the price (20-day $158, 50-day $182, 200-day $195), volume ran 1.49x on the decline, and the 7-day RSI is at an extreme 19 — deeply oversold, with zero basing structure.
Fundamentals — Two conflicting ledgers: FY26 Q4 revenue of $19.2B (+21%) beat, and backlog stands at $638B — yet capex hit $55.7B above guidance with ~$70B more planned for FY27, $32B of operating cash flow nets out to -$23.7B in free cash flow, and the company plans a $40B debt-plus-equity raise. The market has stopped paying for backlog and started asking where the money comes from.
News — Down 24% over nine sessions as the story flipped from 'king of AI backlog' to debt, cash-flow and ratings pressure, with several outlets noting Oracle losing narrative ground to cloud rivals. The next earnings print isn't until September — no official antidote in the near term.
Short-term · 1–3 weeks
NeutralSidelines
Knife-catching is a numbers game, not a courage contest — every day of a nine-day slide looks like the bottom. With a catalyst vacuum (earnings in September) and the raise not yet done, the debt narrative has no rebuttal; oversold can bounce here, it can't reverse.
Entry No knife-catching before a low-volume doji plus a reclaim of $145; below $131 the next magnet is the $120 round numberStop —Target —
Long-term · months+
Neutral
The $638B backlog and the AI-compute-rental model are real; the problem is purely capital structure. If the FY27 raise lands and a free-cash-flow inflection comes into view, today's price will have over-discounted the gloom.
Equity dilution and rising interest costs
Concentration risk around one mega-customer (OpenAI)
Serial negative FCF breeding refinancing dependence
Community Voices
StockTwits · Trending at 18.5: half call it a value pit, half fear a deeper one, and some gripe management has 'gone silent' — the division itself says the trend isn't doneOriginal ↗
WSB · Mentions exploded from 12 to 105 — dip-buy posts are flooding in; retail is catching knives, and the knives are catching retailOriginal ↗
Institutional Views
华尔街共识 · 45 analysts average $255, 94% above spot — but nine straight red days mean the consensus itself is being repriced; don't anchor to stale targets
FX Leaders · The $135 support gave way as cloud-growth and debt worries overshadow the earnings qualitySource ↗
24/7 Wall St · Down 28% in a month; whether the $132 52-week low holds is an open questionSource ↗
0.00%07-04“On the way up everyone swore they owned the supercycle; on the way down they discovered they merely owned SK Hynix's beta — this is what happens when your position gets priced by someone else's earnings”
Technicals — A 12.6% one-day drop through the 50-day at $1,700, with the 20-day far overhead at $1,972. A 74% three-month run left profit-takers fully armed, and a $208 ATR makes 12% daily swings routine. Volume at just 1.09x — not panic but an orderly retreat, which is worse.
Fundamentals — One of the purest plays on NAND repricing — but NAND's supply-demand balance is looser than DRAM/HBM's, so the durability of price hikes is far more contested than Micron's. That cuts valuation elasticity both ways.
News — The most fragile link in the SK Hynix contagion chain: 'slower HBM4 shipments' got generalized into 'memory has topped,' and NAND took the first punch. Coverage flagged the memory trio (MU/SanDisk/WDC) all falling hard — SanDisk's 12.6% close was the deepest of the three.
Short-term · 1–2 weeks
NeutralSidelines
After a 74% three-month run, the holder base amplifies every piece of bad news. The cycle isn't disproven, but momentum is broken — let the profit-takers finish before getting back in line.
Entry A low-volume hold at the $1,580 shelf sets up a tactical bounce; no trend talk below the 20-day at $1,972 — and never carry size overnight in a $208-ATR nameStop —Target —
Long-term · months+
Neutral
NAND offers big elasticity and equally big late-cycle risk; as a second-tier memory name it amplifies the supercycle rather than setting its price.
NAND price hikes underdelivering
Profit-taking overhang not yet cleared
Ongoing sentiment contagion from KOSPI/SK Hynix
Community Voices
WSB · Mentions tripled from 42 to 128 — from cycle religion to stampede in exactly one candleOriginal ↗
New today“Thirty-four billion dollars gone in five days with no filing, no downgrade, no 8-K — a valuation purge never needs a reason; the one who needs a reason is you, reaching for the knife”
Score6/105-day slide -18.6% (~$34B market cap erased)Company news No 8-K, no downgrade, no guidance cutRSI(7) 28.0Rel. volume 2.07xConsensus target $667 (+50%)
Technicals — Broken below every moving average (20-day $499, 50-day $507, 200-day $536). The $440 level — April's platform rim — is the last technical defense. Volume ran 2.07x on the plunge and RSI at 38 isn't even oversold yet; don't rush to call bottoms.
Fundamentals — Q1 EPS of $3.56 on $1.84B revenue (+24%) — the AXON ad engine's profit machine isn't broken. This is a valuation purge, not an earnings problem; but BofA's third-party tracking flagged slower June e-commerce ad growth, which pokes precisely at the most expensively priced part of the story.
News — Monday's 12.65% drop came with zero company-specific catalyst — pure AI/software risk-off front-running; the five-day slide totals 18.6%. BofA calls the selloff 'overdone,' but money is clearly selling first and asking later.
Short-term · 1–3 weeks
NeutralSidelines
A decline without a reason is the hardest to trade — there's no way to know which day the selling exhausts. With volume still heavy and every average broken, the only correct move is waiting.
Entry Long talk resumes only if $440 holds on shrinking volume and the $470 gap gets reclaimed; below $430 the $400 round number is nextStop —Target —
Long-term · months+
Neutral
AXON's profitability is real and rare, and this pullback is dragging the valuation back toward reasonable; but the AI-ad lane is getting crowded and platform pressure from Meta/Google is rising.
New today“Mentions went from 1 to 138 overnight as the 0.7nm chip and a quantum foundry landed on the table together — the difference this time is a billion federal dollars of real skin in the game; revenue five years out, stock price today: give it small-position belief, not full-position faith”
Score7/10WSB mentions 138 (vs just 1 a day earlier)Tech breakthrough World's first sub-1nm 'nanostack' chipQuantum foundry Anderon: $1B from Commerce Dept + $1B from IBMEarnings 7/22Averages Above all MAs, bullish stack
Technicals — Up 0.9% against a broadly red tape. The 20/50/200-day averages ($277/$263/$275) are stacked bullishly and Friday's volume push cleared the 200-day; RSI at 56.7 is healthy with 12.7% of room to the $332 high — one of the few megacaps with both a story and a setup.
Fundamentals — The 0.7nm nanostack packs nearly 100 billion 3D-stacked transistors onto a fingernail — +50% performance or +70% efficiency, +40% SRAM density — with commercialization at least five years out. More tangible: the Anderon quantum foundry in Albany ($1B each from Commerce and IBM) sitting on the Red Hat/consulting cash-flow base.
News — Friday's unveiling of the world's first sub-1nm chip drove a 4.75% volume breakout, and with the cyber alliance plus federal quantum backing, retail chatter detonated overnight. Next stop: July 22 earnings — the narrative needs numbers to take the baton.
Short-term · 1–2 weeks (into 7/22 earnings)
LongLean bullish
Counter-tape strength, a bullish MA stack and a dated catalyst (7/22) all line up; the $275 stop sits under the 20-day/200-day cluster. This trade harvests narrative fermentation, not valuation — earnings day is settlement day, don't overstay.
Entry Pullbacks to $284–290 stay inside the structure; halve the position before earningsStop $275Target $310
Long-term · months+
Neutral
Quantum and advanced nodes are five-year options with some premium already in the price; the Red Hat/consulting cash flows anchor the core case, and the 200-day area — not here — is where long-term money belongs.
A 7/22 earnings miss punctures the hype directly
Quantum/advanced-node commercialization slipping
Catch-down risk in a broader risk-off
Community Voices
WSB · Mentions went 1→138: from ignored to everywhere in one weekend — hype is fuel and altitude at once; check your parachute before boardingOriginal ↗
StockTwits · Trending at 18.9 on the triple narrative of target hikes, federal quantum money and the sub-1nm chip — breakout believers vs the 'five years is forever' camp, head onOriginal ↗
Institutional Views
华尔街共识 · 27 analysts average $300 — just 3.5% above spot; note the consensus hasn't digested the new narrative yet, so treat that number lightly
Barchart · Sub-1nm is a lab milestone pushing past AI limits; the road to revenue remains longSource ↗
Simply Wall St · Sub-1nm launch plus the quantum wafer foundry opening — both catalysts have landedSource ↗
+1.83%07-02“From $225 to $139 in four weeks, with index funds forced to catch $4.3 billion of stock at the summit — now retail debates whether to stand guard beside them; would-be dip buyers should flip the calendar to August 7 first, because the lock-up is when the tide goes out”
Score6/10Off post-IPO high -38%Nasdaq-100 add Effective 7/7 — fastest ever, 15 sessions post-IPODouble-event day 8/6: first earnings + first lock-up expiry (20% of insiders)Starlink 10M+ subscribersAI compute contracts ~$27.8B/yr (incl. Anthropic $1.25B/mo)
Technicals — One month post-IPO there's little map beyond the 20-day at $163 (now resistance); the $136.78 all-time low sits one step below. Volume at 0.8x on the grind lower — no panic, just disappointment, and that kind of decline tends to outlast panic.
Fundamentals — Q1 revenue of $4.7B, Starlink past 10M subscribers, and ~$27.8B/yr of AI-compute contracts (Anthropic at $1.25B/mo, Google at $920M/mo through 2029) — the assets are scarce. But with only 3–5% of shares floating, today's price is set by supply-demand distortion, not fundamental discovery.
News — The fastest-ever Nasdaq-100 inclusion marked the sell-the-news top: passive funds were forced to absorb roughly $4.3B above $145, and the classic post-inclusion fade has since carved the stock down to $139 — below most of that passive cost basis.
Short-term · Into the 8/6 earnings + lock-up
NeutralSidelines
With a 3–5% float, price discovery waits until lock-ups release supply. First earnings and first expiry on the same day make 8/6 a revaluation event, not a trading day.
Entry No position before the 8/6 double event; a break of the $136.78 IPO low means lock-up front-running is accelerating, while bounces first face the $150 gapStop —Target —
Long-term · months+
Neutral
The only scarce 'space + AI compute' asset with an intact long-term story; but the IPO premium isn't fully washed out, and successive lock-up waves stand between here and honest valuation.
Lock-up supply waves starting 8/6
Wholesale repricing as the float expands
Event risk from Starship mission failures
Signal BacktestCumulative +1.83%price itself -11.68%1/1 closed trades wonprofitable since 07-04
07-02Long$157.54 → closed $160.4207-07+1.83%
Community Voices
WSB · Mentions jumped 90→237 with 2,748 upvotes, the board's highest — 'index funds are standing guard at the peak, do we join them?' is the headline thread; sheep or lead wolf, the lock-up date will tellOriginal ↗
+4.47%07-04“Korea hit the circuit breaker and the arms dealer only caught a stray round — $196 is the verdict line: above it this is a gift dip, below it a new story begins; don't pronounce sentence on your own position before the market does”
Score7/10Day / week -3.5% / +4.7%RSI(14) 49.9Stop $196 (above the 200-day at $191.8)WSB mentions 115 (3.3x)Consensus target $314 (+54%)
Technicals — Even after the 3.5% giveback the week is still +4.7%, holding a step above the 20-day at $201.9; volume at 0.84x shows no loosening of the holder base. The $196 stop sits in the buffer above the 200-day at $191.8 — a clean structure.
Fundamentals — The arms-dealer logic is untouched: Meta's 14GW, Microsoft and Anthropic are all still building. HBM sits on NVIDIA's cost line, so a cooling memory market is neutral-to-positive for margins — and its order visibility remains the best in the market.
News — Korea's semiconductor circuit-breaker rippled through the global compute chain; with zero company-specific negatives, the 3.5% dip is pure sentiment contagion — and WSB chatter has flipped from 'it's up too much' to 'do we buy this dip.'
Short-term · 1–3 weeks
LongBullish
Stray rounds hurt sentiment, not the order book. The stop hugs the 200-day's upper rim and the break-means-exit discipline stands — let $196 make the decision, not the panic.
Entry Hold; a stabilized retest of $200 (20-day plus round-number support) is the re-entry spotStop $196Target $235
Long-term · months+
Accumulate
The only full-stack arms dealer in the AI compute race, with platform lock-in (CUDA + networking + systems) still deepening.
HBM supply bottlenecks pacing shipments
Hyperscaler in-house silicon diverting spend
Export-control escalation
Signal BacktestCumulative +4.47%price itself +3.01%profitable since 07-07
07-04Long$194.83 → open → $203.53+4.47%
Community Voices
WSB · Mentions went 35→115: one red day tripled the chatter — it's still everyone's frame of referenceOriginal ↗
Institutional Views
华尔街共识 · 66 analysts average $314 — 54% above spot; 1.14 rating, near strong buy
-5.96%07-07“1.2% from the stop with an $18.6 ATR — one ordinary swing can trigger the exit, so every day into 7/22 is a tightrope walk; the 480k-delivery card has already been played, and what earnings will flip over is the margin hole card — right now discipline is worth more than faith”
Score7/10To the stop $390 — just 1.2% awayEarnings 7/22Q2 deliveries 480,126 (+25%, beat by ~74k)RSI(14) 47.2ATR $18.6
Technicals — Down 3.2% through the 20-day at $400.7 with the $390 stop right in its face; 0.7x volume shows no active flight — but no bid either. The 50-day at $409.6 and 200-day at $418 cap the upside in sequence.
Fundamentals — Q2's 480,126 deliveries were the strongest second quarter ever and the first year-over-year growth in two years; the only question for 7/22 is whether that volume was bought with margin (price cuts / financing subsidies). EPS consensus sits flat at $0.27.
News — No company-specific negatives — just tape sympathy. The stock popped 6.6% on July 6 on robotaxi progress and the delivery beat; into earnings, the market keeps repricing the same hand.
Short-term · Into 7/22 earnings
LongBullish
The stop is 1.2% away: if it triggers, walk — earnings are the next train. If it holds, the trend is intact and the position rides unchanged into 7/22. The delivery beat is priced; earnings bet the margin, and that's not this position's wager.
Entry Hold as-is, no adds, no trims; a $390 break means exit immediately — don't wait for earningsStop $390Target $430
Long-term · months+
Neutral
Robotaxi/FSD and storage are real second curves, but the valuation already carries heavy option value; long-term money should wait for the margin answer at earnings.
Margin miss
Brand risk from Musk's political exposure
Global squeeze from Chinese OEMs
Signal BacktestCumulative -5.96%price itself -7.18%
07-07Long$419.77 → open → $394.76-5.96%
Institutional Views
华尔街共识 · 51 analysts average $407 — only 3.2% above spot at a 1.77 rating; the consensus is no longer cheap, and all the disagreement is stacked on the earnings table
Electrek · Q2 deliveries of 480,126, up 25% — a big beatSource ↗
New today“The son (Kunlunxin) is shopping a $50 billion valuation while the father's whole market cap is $36 billion — and subscribers must bundle 3–7x their allocation in chip orders; that's not an IPO, it's a group-buy. Enjoy the 'rich kid, proud parent' story as fiction — the tape cast its no vote this morning”
Score6/10This morning Down as much as 8%, leading HS Tech declinersKunlunxin valuation target $50B vs Baidu's ~$36B market capBundling clause Subscribers must buy 3–7x in chipsQ1 net income -55.3%Search ads -28.6% YoY
Technicals — Broke the 20-day (HK$109.8) on 2.26x volume this morning, touching HK$104.3 at the low. RSI at 40 is neutral-weak, and the 52-week low at HK$84.2 is still 20% below — neither oversold nor supported.
Fundamentals — AI revenue crossed half the mix (52%) for the first time, yet profit didn't follow: Q1 net income fell 55.3% and search ads bled 28.6% — faster than AI can transfuse. Kunlunxin is the most valuable asset on the books (China's #2 AI-chip shipper), but the more the spin-off succeeds, the more concrete the hollowed-parent worry becomes.
News — Kunlunxin is running a dual-track IPO (confidential HKEX filing plus STAR-board tutoring) with bank valuations wildly split ($16B–$57B), and the bundling clause has raised channel-stuffing questions. Baidu led HS Tech lower this morning with fellow model-play Zhipu down 10% — the other face of the AI-asset repricing.
Short-term · 1–3 weeks
NeutralSidelines
Heavy-volume panic, bleeding fundamentals and a contested spin-off price — three uncertainties stacked. On the left side your only friend is price, and this price isn't cheap enough yet.
Entry The HK$100 round number is the first watch level; skip every bounce until HK$110 (the 20-day) is reclaimedStop —Target —
Long-term · months+
Neutral
A sum-of-the-parts (Kunlunxin + cloud + Apollo) clearly covers the market cap, but the spin-off-discount-plus-bleeding-core combination has rarely paid shareholders; settle the full bill after Kunlunxin prices.
Search-ad bleed outpacing AI transfusion
Kunlunxin IPO pricing or timeline disappointing
Beta to a broad AI-model-stock ebb
Community Voices
东财股吧 · The 'proud parent' and 'selling the son to fund retirement' camps are at war — retail is really arguing one question: after the chip unit lists, what's left of BaiduOriginal ↗
Institutional Views
华尔街共识 · 18 analysts average HK$179.5 — 69% above spot; the chasm between consensus and tape is itself the answer to the position question
高盛（转引） · Benchmarked to Cambricon, Baidu's Kunlunxin stake is worth a lot on paperSource ↗
澎湃新闻 · Kunlunxin's assets and baggage: #2 domestic shipper, deeply tied to Baidu's own demandSource ↗
New today“The CXO duo has one name printing highs and the other pressed against them — Asymchem is up 39% in a month with HK$130 one kick away. There's no shame in buying a breakout; the shame is buying one without a stop. Below HK$115, this story is no longer yours”
Score7/101-month +38.7%To 52-wk high HK$130 — one step awayRSI(14) 66.8Sector echo WuXi Bio (2269, held) printing highs in tandemBank target avg HK$136.1
Technicals — A fully bullish MA stack (20-day HK$108, 50-day HK$101, 200-day HK$89), with this morning's 4.9% push on 1.24x volume pressing the HK$130 prior high. This isn't a one-day melt-up chase — it's a month of stair-step gains, and RSI at 66.8 is warm, not burnt.
Fundamentals — CXO demand is flowing back — innovative-drug licensing plus a warming peptide/small-molecule order cycle has made interim-season order visibility a safe-harbor theme for HK money. The July 8 H-share incentive grant (at RMB 1.00) locks in the core team.
News — Shares rose 6.7% on July 9 when the incentive grant was disclosed; with WuXi Bio printing highs in tandem, CXO is one of the few long themes on a red tech tape. Two bank buy ratings in 90 days, average target HK$136.1.
Short-term · 1–3 weeks
LongLean bullish
Breakout channel, sector confirmation (2269 at highs too) and a stair-step monthly climb — triple confirmation. The HK$115 stop allows 1.5 ATRs (HK$8.75); a break means being wrong, and the entire dignity of new-high trading lives in the stop.
Entry Scale in inside HK$122–128; a volume close above HK$130 confirms the breakoutStop HK$115Target HK$145
Long-term · months+
Accumulate
A warming CXO cycle with rising utilization, big order elasticity in peptides (GLP-1 spillover), and the RMB-1 incentive grant aligning management.
雪球 · CXO chatter is heating up — bagholders from the last cycle top are still lecturing new buyers, which is the standard soundtrack of an advance's first halfOriginal ↗
Institutional Views
华尔街共识 · 7 analysts average HK$133 — 4.2% above spot at a 1.07 rating; targets are being chased higher by the price
搜狐财经 · H-share incentive granted; two buy ratings in 90 days with an average target of HK$136.1Source ↗
+10.77%07-02“After a 15% week, one flat day is a rest, not a reversal — and closing flat while HS Tech bled is independence worth more than the gain itself; with the stop lifted above cost, others fight vertigo while you just read the ledger”
Technicals — A quiet consolidation after the 15% week: the 7-day RSI at 74.8 is short-term hot but the daily RSI of 56 is healthy. The 20-day sits far below at HK$101.4 with the 50-day at HK$116.8 as the next gate. Flat this morning against a falling tech index — relative strength intact.
Fundamentals — The FY27Q1 preview points to cloud growth accelerating to ~45% (above expectations) with EBITA margin reaching low double digits; Qwen 4.0 plus the QoderWork/Wukong/MuleRun productivity suite gives the 'reprice AI assets' narrative something real to hold.
News — After the two-stage jump (+12% on 7/8, +5% on 7/9), rotation has settled in and the banks' 'time to reprice AI assets' call keeps working; a flat close on a red HS Tech morning says the holder base hasn't loosened.
Short-term · 1–3 weeks
LongBullish
Low-volume consolidation after a surge is a bullish shape, counter-tape strength is valuable, and the stop already sits above cost — this is the textbook let-it-run setup, not a take-profit one.
Entry Hold; a pullback to HK$105–107 remains the only dignified boarding zone for those who missed itStop HK$105Target HK$130
Long-term · months+
Accumulate
The cloud+AI re-rating is still early with a valuation discount to US peers as the cushion; core-commerce cash flow funds the capex cycle.
LLM monetization underdelivering
Regulatory whiplash
Weak consumption dragging the core
Signal BacktestCumulative +10.77%price itself +17.75%0/1 closed trades wonprofitable since 07-09
07-02LongHK$94.5 → closed HK$94.107-04-0.42%
07-08LongHK$99.6 → open → HK$110.8+11.24%
Community Voices
雪球 · The 'phase two of the AI re-rating' camp battles the 'take the money' camp — the sidelined wait for a dip, and a dip that never comes is the market's cruelest trickOriginal ↗
0.00%07-09“An RSI of 26.8 on a stock already halved in three months can still fall another thirty percent — with CATL's mine restarting and West Africa ramping, supply-side bad news is a rainy season, and you don't step out before seeing an umbrella (volume drying up into a base); this morning's +2.8% was just a minute spent under the eaves”
Score5/10RSI(14) 26.8Week / month / 3M -15.6% / -30.5% / -49.9%Lithium carbonate RMB 205k → 147k per tonneSupply side CATL mine restarting + West Africa's largest mine onstreamConsensus target HK$85.7 (+105%)
Technicals — Every average points down and price sits 29% below the 200-day; this morning's 2.8% uptick is an RSI-26 technical gasp on 0.8x volume — even the bounce drew no crowd. The 52-week low at HK$23.8 is a reminder of how much room remains below.
Fundamentals — The earnings-vs-price rift: volume growth plus hedging may keep the interim report respectable, but the market is pricing 2027 oversupply — Goldman sees the lithium market tipping into surplus in H2, so earnings-delivery day doubles as money-exit day.
News — Tianqi's A-shares limit-downed on July 8 as supply-increase headlines hammered the sector; NBD reports money voting with its feet just as lithium earnings deliver. This morning HK lithium bounced together (Tianqi +3.3%) — the weekly wounds are nowhere near healed.
Short-term · 1–3 weeks
NeutralSidelines
Oversold guarantees bounce elasticity, not a reversal. Oversupply gets priced over quarters, and every day on the left side has more patience than you do.
Entry Three conditions, no exceptions: volume below 0.7x, the weekly chart stabilizing, and lithium futures basing; below the HK$40 round number, HK$35 is nextStop —Target —
Long-term · months+
Neutral
Global resource depth plus vertical integration make this next-cycle bottom inventory — but the left side is long; talk allocation only after supply-clearing signals (curtailments, bankruptcies, capex collapse).
Deepening surplus and a second leg down in lithium prices
Twin selling pressure across A and H shares
Hedging gains masking spot deterioration
Community Voices
雪球 · Cries of 'lithium is being slaughtered' flood the feed — retail counts bottoms while the bottom counts retailOriginal ↗
Institutional Views
华尔街共识 · 11 analysts average HK$85.7 — 105% above spot; that's a relic of the last cycle, don't anchor to it
高盛（转引） · Sees the lithium market in surplus in H2Source ↗
每日经济新闻 · Lithium stocks grow earnings while money walks; supply additions cap the multipleSource ↗
Down 0.8% to $749.17 — defensives held the index up; tonight's CPI plus the megabank prints referee the next move(Long-term: Core allocation unchanged; manage event-week risk with sizing, not timing)
Down 1.9% to $711.74 on the semis drag; RSI back to midfield, with the 50-day lurking under the $700 round number(Long-term: Tech core stays put; volatility is the holding fee)
Down 2.1% to $115.58 as the tech-sector fund tracks the semis pullback — same rhythm as QQQ(Long-term: The long-term tech-beta allocation case is unchanged)
Down 8.5% to $168.02 on KOSPI's -10% circuit-breaker day — the +62% YTD tide is going out; catch this knife only in tranches(Long-term: Korea's semis concentration makes volatility destiny; position sizing first)
Down 4.1% to $101.88 — Taiwan rode the semis sympathy; a TSMC-chain beta day(Long-term: Twin geopolitical and semis exposure — pair any allocation with a hedge)
Down 1.5% to $35.39 with the EM pullback — though pricier oil actually leans supportive for Brazil(Long-term: High dividends plus commodity exposure — a genuine diversifier)
Down 2.6% to $367.13 on a war-escalation day — in a liquidity squeeze even gold becomes an ATM; short-term signals are distorted(Long-term: The allocation case is intact; panic selling opens the long-term add-watch window)
Up 8.4% to $117.79, the direct beneficiary of Iran's 'unnavigable' Hormuz call — geopolitical premium arrives fast and leaves faster; chasing it is betting on war bulletins(Long-term: Futures-based commodity ETFs bleed roll costs — not a long-term hold)
Up 3.0% to $56.74 as energy's geopolitical-hedge value shows — a small sleeve is insurance, not speculation(Long-term: An energy sleeve is the portfolio's geopolitical shock absorber, dividends as the floor)
Up 4.2% to $165.19 — E&P offers more torque than XLE; the aggressive flavor of the same hedge(Long-term: High-beta energy exposure — keep the position small)
Flat at $100.14 on 7.6x volume — the GENIUS-Act stablecoin money-market ETF is a cash substitute, not a trade(Long-term: Money-market in nature; the yield is the entire expectation)
Down 14.0% to $165.37, the 3x casualty of the SK Hynix shockwave — a 14% single-day loss is the entire argument against holding this long(not for long-term holding)
Down 24.7% to $419.19, the 3x amplification of KOSPI's breaker day — a 25% one-day loss is a leveraged ETF's funeral; view from a distance(not for long-term holding)
Down 6.0% to $90.20 with dual-channel resonance — uranium's AI-nuclear story is buying tickets for round two on this dip; RSI 31 puts it on watch, wait for the base
Up 2.6% to $20.18, pressing the 52-week high — US pipeline assets under a Hormuz premium are the energy chain's steadiest beta; revisit on a $19.50 pullback
Up 90.7% to $21.38 on 41x volume — a biotech microcap doubling in a day is a lottery draw, not a signal; winners cash out, everyone else skip the makeup ticket
Down 7.8% to $67.58 while WSB mentions exploded 8x — space names got caught in the geopolitical crossfire; August's triple BlueBird launch and 8/10 earnings are the next stop — watchlist, not knife-catch
Down 0.9% to $1,045.91 — tonight's print weighs the SpaceX-IPO lead-underwriter cut in public; with consensus targets at spot, enjoy the show from the seats
Up 9.5% this morning at HK$689.00, a V-snapback the day after the cornerstone lock-up (7/13) landed — bad-news-spent buying, but a -16.9% week of roller coaster isn't for weak hearts
Up 3.3% this morning at HK$230.00 — a technical gasp after the lock-up halving; of the three conditions (volume dry-up, base, 20-day reclaim), zero are met — keep waiting
Up 3.3% this morning at HK$34.16, breathing in sync with Ganfeng — at 13–15x forward it's the cheaper twin, but cheap has never stopped a lithium price from falling; sidelines
